Loading…
Neuronetics, Inc. is projected to rise to $1.24 by 2027, a +1% move from its current price of $1.22. STIM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.14 | $1.22 | $1.30 | -0.11% |
| May 30 | $1.11 | $1.22 | $1.33 | -0.22% |
| May 31 | $1.09 | $1.22 | $1.36 | -0.33% |
| Jun 1 | $1.07 | $1.21 | $1.38 | -0.44% |
| Jun 2 | $1.05 | $1.21 | $1.40 | -0.55% |
| Jun 3 | $1.04 | $1.21 | $1.41 | -0.66% |
| Jun 4 | $1.02 | $1.21 | $1.43 | -0.77% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.02 | $1.21 | $1.43 | -0.77% |
| Week 2 | $0.949 | $1.20 | $1.52 | -1.53% |
| Week 3 | $0.8932 | $1.19 | $1.59 | -2.28% |
| Week 4 | $0.8476 | $1.18 | $1.65 | -3.03% |
| Week 5 | $0.8086 | $1.17 | $1.70 | -3.78% |
| Week 6 | $0.7744 | $1.16 | $1.75 | -4.52% |
| Week 7 | $0.7437 | $1.16 | $1.80 | -5.25% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Neuronetics, Inc. (STIM) is a healthcare company that provides in office treatments for neurohealth disorders in the United States and internationally. It provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder.
Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.
The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Neuronetics, Inc. trades under the symbol STIM in the Healthcare sector. Its current price is $1.20 and its market cap is $83.51M. It ranks 4340.
The forecast for the asset shows a bullish trajectory in the years ahead, with the average price rising to $2.08 by 2030 and to $6.71 by 2050, while the maximum price could reach $15.44 by 2050.
The forecast also shows early neutral years: 2026 avg $1.20 and 2027 avg $1.19, with ROIs near 0%.
Overall, the longer-term outlook is bullish.
A major floor 56.3% below — a decisive break under it would weaken the trend.
The nearest floor, 3.3% below — buyers have tended to step in here.
The nearest ceiling, 77.9% above — a clean break opens room to run.
A major ceiling 106.0% above — clearing it would confirm fresh momentum.
Key STIM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of STIM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.20 | Buy | $1.22 | Sell |
| MA 10 | $1.25 | Sell | $1.28 | Sell |
| MA 20 | $1.53 | Sell | $1.39 | Sell |
| MA 50 | $1.50 | Sell | $1.48 | Sell |
| MA 100 | $1.56 | Sell | $1.62 | Sell |
| MA 200 | $2.03 | Sell | $1.96 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.69 | Neutral |
| Stoch RSI (14) | 13.22 | Buy |
| CCI (20) | -66.56 | Neutral |
| Williams %R (14) | -93.94 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -26.28 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 6.06 | Buy |
| TRIX (15) | -0.62 | Sell |
| Awesome (5,34) | -0.31 | Sell |
| Ultimate (7,14,28) | 29.37 | Buy |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 1.20 | Buy |
| ADX (14) | 19.67 | Neutral |
| ATR (14) | 0.08 | Info |
The 30-day technical picture is bearish. RSI14 is 40, indicating subdued momentum, and the price is positioned below key moving averages.
SMA50 is $1.50 and SMA200 is $2.06, signaling near-term downside pressure. Support is at $1.18 and resistance at $2.17.
The thirty-day range runs from $0.772 to $1.87, framing near-term volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.18 | $1.22 | $1.61 | 0% | Neutral | |
| $0.8901 | $1.24 | $1.86 | +1% | Neutral | |
| $1.18 | $1.74 | $2.78 | +43% | Bullish | |
| $1.36 | $2.11 | $3.53 | +73% | Bullish | |
| $1.33 | $2.17 | $3.78 | +78% | Bullish | |
| $1.12 | $1.90 | $3.43 | +56% | Bullish | |
| $1.09 | $1.94 | $3.60 | +59% | Bullish | |
| $1.11 | $2.05 | $3.92 | +68% | Bullish | |
| $1.20 | $2.30 | $4.50 | +88% | Bullish | |
| $1.59 | $3.17 | $6.36 | +160% | Bullish | |
| $1.39 | $3.10 | $6.81 | +154% | Bullish | |
| $3.21 | $7.12 | $16.39 | +484% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.18 | $1.22 | $1.44 | +0.00% |
| June 2026 | $0.9243 | $1.11 | $1.38 | -9.14% |
| July 2026 | $0.9048 | $1.10 | $1.41 | -0.45% |
| August 2026 | $0.9611 | $1.19 | $1.54 | +7.65% |
| September 2026 | $0.9314 | $1.16 | $1.54 | -2.01% |
| October 2026 | $0.8701 | $1.10 | $1.47 | -5.62% |
| November 2026 | $0.8995 | $1.15 | $1.55 | +4.32% |
| December 2026 | $0.9138 | $1.17 | $1.61 | +2.48% |
Click any year to see its month-by-month STIM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, STIM could reach as high as $1.61, with a base case around $1.22 and support toward $1.18 — roughly 0% from $1.22. Price action looks broadly range-bound.
Expect STIM to range from $0.8901 to $1.86 through 2027. The $1.24 average target implies a +1% move from current prices. That is up +1% on the projected 2026 average. A consolidation phase looks the most probable path here.
The STIM price prediction for 2028 points to an average of $1.74 (low $1.18, high $2.78) — a potential gain of +43% on today's $1.22. Momentum favours further upside here.
In 2029, STIM is projected to trade between $1.36 and $3.53, averaging $2.11 — a potential gain of +73% from today's $1.22. That is up +21% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Neuronetics, Inc.'s 2030 outlook centres on $2.17, within a $1.33 to $3.78 range. That is up +3% on the projected 2029 average. That marks a +78% change versus current levels. Momentum favours further upside here.
By 2031, STIM could reach as high as $3.43, with a base case around $1.90 and support toward $1.12 — roughly +56% from $1.22. Buyers look set to stay in control over this stretch.
Expect STIM to range from $1.09 to $3.60 through 2032. The $1.94 average target implies a +59% move from current prices. That is up +2% on the projected 2031 average. Momentum favours further upside here.
The STIM price prediction for 2033 points to an average of $2.05 (low $1.11, high $3.92) — a potential gain of +68% on today's $1.22. Buyers look set to stay in control over this stretch.
In 2034, STIM is projected to trade between $1.20 and $4.50, averaging $2.30 — a potential gain of +88% from today's $1.22. That is up +12% on the projected 2033 average. Momentum favours further upside here.
Neuronetics, Inc.'s 2035 outlook centres on $3.17, within a $1.59 to $6.36 range. That is up +38% on the projected 2034 average. That marks a +160% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, STIM could reach as high as $6.81, with a base case around $3.10 and support toward $1.39 — roughly +154% from $1.22. Momentum favours further upside here.
Expect STIM to range from $3.21 to $16.39 through 2050. The $7.12 average target implies a +484% move from current prices. That is up +130% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in STIM today (≈ 819.672131 STIM) could be worth
$5,839.32
+$4,839.32 (+484%) by 2050 · US Dollar
Based on the average projected STIM price of $7.12 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in STIMwould be worth at today's price.
$1,000 invested in STIM on May 27, 2025 (≈ 251.889167 STIM) would be worth
$307.3
-$692.7 (-69.3%) today · 0.31× · US Dollar
Based on a STIM entry price of $3.97 vs. today's $1.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.19 | $1,025.21 | +2.5% |
| 1 month ago | $1.69 | $721.89 | -27.8% |
| 3 months ago | $1.42 | $859.15 | -14.1% |
| 6 months ago | $1.49 | $818.79 | -18.1% |
| 1 year ago | $3.97 | $307.3 | -69.3% |
| All time (5.0y) ago | $13.99 | $87.21 | -91.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our STIM forecast.
Our base-case forecast reaches $2.40 around 2035.
Implied market cap at $2.40: $167.01M
In 2026 the forecast shows min $1.18, avg $1.20, max $1.57 with ROI 0 and sentiment NEUTRAL. In 2027 the forecast shows min $0.8561, avg $1.19, max $1.79 with ROI -0.8 and sentiment NEUTRAL.
From 2028 onward the outlook turns bullish: 2028 min $1.16, avg $1.72, max $2.75 with ROI 43.1 and sentiment BULLISH. 2029 min $1.31, avg $2.04, max $3.42 with ROI 69.8 and sentiment BULLISH. 2030 min $1.28, avg $2.08, max $3.63 with ROI 73.4 and sentiment BULLISH.
2031-2035 stay bullish with 2031 min $1.10, avg $1.86, max $3.36 (ROI 55.3), 2032 min $1.05, avg $1.86, max $3.46 (ROI 55.1), 2033 min $1.07, avg $1.97, max $3.76 (ROI 64.2), 2034 min $1.16, avg $2.23, max $4.36 (ROI 85.4), 2035 min $1.51, avg $3.02, max $6.05 (ROI 151.6); sentiment BULLISH. 2040 min $1.35, avg $3.00, max $6.59 with ROI 149.7 and sentiment BULLISH.
The far horizon shows 2050 with min $3.02, avg $6.71, max $15.44, ROI 459.5 and sentiment BULLISH.
Tap a question to reveal the answer.
2030 forecast: min $1.28, avg $2.08, max $3.63; ROI 73.4%; sentiment BULLISH.
The forecast shows a neutral stance in 2026-2027, then a bullish trajectory with higher averages and up to 459.5% ROI by 2050, with a 2050 avg of $6.71 and max of $15.44.
Yes. The forecast max for 2050 is $15.44, with a 2050 min of $3.02 and avg of $6.71 (ROI 459.5; sentiment BULLISH).
Current price is $1.20 and market cap is $83.51M.
The 30-day range is from $0.772 to $1.87.
Neuronetics, Inc. Community Discussion
0Share your Neuronetics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.